Avricore Health Inc (AVCR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avricore Health Inc (AVCR) has a cash flow conversion efficiency ratio of -0.130x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-25.44K ≈ $-18.40K USD) by net assets (CA$195.20K ≈ $141.21K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Avricore Health Inc (AVCR) total market value for the company's overall valuation and market capitalisation.
Avricore Health Inc - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Avricore Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Avricore Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avricore Health Inc ranked by their cash flow conversion efficiency. Explore Avricore Health Inc (AVCR) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cahaya Bintang Medan Tbk Pt
JK:CBMF
|
0.000x |
|
NuCana PLC
NASDAQ:NCNA
|
-0.038x |
|
MEKICS Co Ltd
KQ:058110
|
-0.012x |
|
Methanor
PA:ALMET
|
13.967x |
|
COLLPLANT BIOTECH. IS-01
F:CPT
|
-0.624x |
|
Anglo Asian Mining Plc
LSE:AAZ
|
0.159x |
|
Philly Shipyard ASA
OL:PHLY
|
-4.976x |
|
Polar Capital Global Healthcare Trust plc
LSE:PCGH
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Avricore Health Inc (2000–2025)
The table below shows the annual cash flow conversion efficiency of Avricore Health Inc from 2000 to 2025. View AVCR stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$389.56K ≈ $281.80K |
CA$-789.93K ≈ $-571.43K |
-2.028x | -497.17% |
| 2024-12-31 | CA$1.97 Million ≈ $1.42 Million |
CA$1.00 Million ≈ $726.72K |
0.511x | +55.31% |
| 2023-12-31 | CA$2.01 Million ≈ $1.45 Million |
CA$660.40K ≈ $477.73K |
0.329x | +247.46% |
| 2022-12-31 | CA$1.96 Million ≈ $1.42 Million |
CA$-437.83K ≈ $-316.72K |
-0.223x | +60.32% |
| 2021-12-31 | CA$2.20 Million ≈ $1.59 Million |
CA$-1.23 Million ≈ $-892.77K |
-0.562x | -132.79% |
| 2020-12-31 | CA$-714.04K ≈ $-516.53K |
CA$-1.22 Million ≈ $-884.99K |
1.713x | +16.18% |
| 2019-12-31 | CA$-465.45K ≈ $-336.70K |
CA$-686.41K ≈ $-496.54K |
1.475x | +175.74% |
| 2018-12-31 | CA$885.97K ≈ $640.89K |
CA$-1.73 Million ≈ $-1.25 Million |
-1.947x | -175.22% |
| 2017-12-31 | CA$2.50 Million ≈ $1.81 Million |
CA$-1.77 Million ≈ $-1.28 Million |
-0.707x | +34.26% |
| 2016-12-31 | CA$1.92 Million ≈ $1.39 Million |
CA$-2.06 Million ≈ $-1.49 Million |
-1.076x | -81.28% |
| 2015-12-31 | CA$3.25 Million ≈ $2.35 Million |
CA$-1.93 Million ≈ $-1.39 Million |
-0.594x | -34.10% |
| 2014-12-31 | CA$3.35 Million ≈ $2.43 Million |
CA$-1.48 Million ≈ $-1.07 Million |
-0.443x | +45.59% |
| 2013-12-31 | CA$663.10K ≈ $479.67K |
CA$-539.52K ≈ $-390.28K |
-0.814x | -129.81% |
| 2012-12-31 | CA$436.69K ≈ $315.89K |
CA$-154.61K ≈ $-111.84K |
-0.354x | -897.35% |
| 2011-12-31 | CA$-1.32 Million ≈ $-955.71K |
CA$-58.66K ≈ $-42.44K |
0.044x | -92.97% |
| 2010-12-31 | CA$-1.07 Million ≈ $-771.49K |
CA$-673.34K ≈ $-487.08K |
0.631x | +104.18% |
| 2009-12-31 | CA$239.30K ≈ $173.10K |
CA$-3.61 Million ≈ $-2.61 Million |
-15.095x | -2699.35% |
| 2008-12-31 | CA$1.73 Million ≈ $1.25 Million |
CA$-930.62K ≈ $-673.20K |
-0.539x | -52.29% |
| 2007-12-31 | CA$2.48 Million ≈ $1.79 Million |
CA$-876.72K ≈ $-634.21K |
-0.354x | +25.57% |
| 2006-12-31 | CA$779.90K ≈ $564.17K |
CA$-371.02K ≈ $-268.39K |
-0.476x | +76.21% |
| 2005-12-31 | CA$157.37K ≈ $113.84K |
CA$-314.66K ≈ $-227.62K |
-1.999x | -33.90% |
| 2004-12-31 | CA$271.03K ≈ $196.06K |
CA$-404.72K ≈ $-292.77K |
-1.493x | -58.17% |
| 2003-12-31 | CA$800.22K ≈ $578.87K |
CA$-755.46K ≈ $-546.49K |
-0.944x | -1330.14% |
| 2002-12-31 | CA$182.98K ≈ $132.37K |
CA$14.04K ≈ $10.16K |
0.077x | +119.37% |
| 2001-12-31 | CA$184.42K ≈ $133.41K |
CA$-73.06K ≈ $-52.85K |
-0.396x | -202.19% |
| 2000-12-31 | CA$79.95K ≈ $57.83K |
CA$-10.48K ≈ $-7.58K |
-0.131x | -- |
About Avricore Health Inc
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to A… Read more